Premium
The first report of two homozygous sequence variants in FKRP and SELENON genes associated with syndromic congenital muscular dystrophy in Iran: Further expansion of the clinical phenotypes
Author(s) -
Mohamadian Malihe,
Naseri Mohsen,
Ghandil Pegah,
Bahrami Afsane,
Momen Ali Akbar
Publication year - 2020
Publication title -
the journal of gene medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.689
H-Index - 91
eISSN - 1521-2254
pISSN - 1099-498X
DOI - 10.1002/jgm.3265
Subject(s) - proband , genetics , sanger sequencing , exome sequencing , congenital muscular dystrophy , muscular dystrophy , missense mutation , phenotype , gene , biology , frameshift mutation , bioinformatics , medicine , dna sequencing , mutation
Background Congenital muscular dystrophy (CMD) refers to hypotonia and delayed motor development that is manifested at or near the birth. Additional presentations have been observed in CMD syndromes. Methods Thorough clinical examinations were performed on two unrelated Iranian families with typical symptoms of CMD and uncommon features such as intellectual disability and nephrolithiasis. The genomic DNA of probands were subjected to whole exome sequencing. Following the detection of candidate variants with a bioinformatic pipeline, the familial co‐segregation analysis was carried out using polymerase chain reaction‐based Sanger sequencing. Results We identified a missense homozygous variant in the fukutin‐related protein ( FKRP ) gene (c.968G>A, p.Arg323His) related to CMD‐dystroglycanopathy type B5 (MDDGB5) and a frameshift homozygous variant in the selenoprotein N ( SELENON ) gene (c.1446delC, p.Asn483Thrfs*11) associated with congenital rigid‐spine muscular dystrophy 1 (RSMD1), which were completely segregated with the phenotypes in the families. These variants were not found in either the 1000 Genomes Project or the Exome Aggregation Consortium. The present study provides the first report of these homozygous sequence variants in Iran. Moreover, our study was the first observation of nephrolithiasis in FKRP‐related dystroglycanopathy and intellectual disability in SELENON‐related myopathies. Based on in silico studies and molecular docking, these variations induced pathogenic effects on the proteins. Conclusions Our findings extend the genetic database of Iranian patients with CMD and, in general, the phenotypical spectrum of syndromic CMD. It is recommended to consider these variants for a more accurate clinical interpretation, prenatal diagnosis and genetic counseling in families with a history of CMD, especially in those combined with cognitive impairments or renal dysfunctions.